Participants who were pregnant or breastfeeding or treated with nebulized NAC, newly prescribed mucoactive drugs, or subjected to changes in mucoactive drugs dosage within 4 weeks of treatment, and those with a history of hypersensitivity to NAC or contraindications for NAC, were excluded
Follow-Up and Monitoring We schedule follow-up appointments to track your progress, adjust your protocol if needed, and ensure you are seeing the results you expect
It increases p53 expression in breast cancer cells, and therefore significantly reduces cell proliferation.8 Impaired p53 expression is associated with many human cancers
R., Fern, J., Diguez, C., Lpez, M., & Milbank, E
Ive lost about 70 pounds
Too often, prior authorization requirements delay access to essential medicationseven for long-standing, stable therapies or simple dose changes ordered by a physician